China’s National Medical Products Administration (NMPA) has granted approval to Hangzhou Biosunpharma Co., Ltd. for...
Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) announced that its US partner Dianthus Therapeutics (NASDAQ:...
Simcere Pharmaceutical Group Limited (HKG: 2096) announced it has received clinical trial approval from China’s...
Alebund Pharmaceuticals, a Shanghai-based biopharmaceutical company focused on kidney disease therapeutics, has filed its prospectus...
Senhwa Biosciences, Inc. (TPE: 6492) announced on May 5, 2026, the initiation of a global,...
Amgen (NASDAQ: AMGN) announced on May 4, 2026, an additional $300 million investment in its...
Pfizer Inc. (NYSE: PFE) reported first quarter 2026 financial results on May 5, 2026, with...
The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical...
UCB (EBR: UCB) announced on May 3, 2026, a definitive agreement to acquire Candid Therapeutics...
AstraZeneca plc (NYSE: AZN) announced that the US Food and Drug Administration’s (FDA) Oncologic Drugs...
SiranBio, a Suzhou-based siRNA drug developer, announced a strategic licensing agreement with GlaxoSmithKline plc (GSK;...